New vaccine against cervical cancer

The international symposium held in Turkey, tabled a new option in the treatment and prevention of gynecological cancer. Especially cervical cancer The new generation vaccine, which is effective against nine types of HPV, is said to be among the protective approaches against cancer.

European Vice President of Gynecological Oncology Association (ESGO) Assoc. Dr. Murat Gultekin, associations, international participation organized by "Women for Cancer Prevention Symposium" said the recently held successfully in Turkey.

Gültekin, the gynecologic cancer of the meeting in the diagnosis, treatment, new research, protective methods until the discussion of each issue was discussed. Gültekin stated that new screening methods have been identified and how to integrate vaccines with these methods, Gultekin stated at the meeting that several good news were provided about the methods of treatment and prevention of gynecological cancers.

Gültekin said that one of scientific studies is protective surgery in ovarian cancer, especially in genetic cases. Gültekin reported that a significant proportion of the ovarian cancers were caused by the tube, according to the studies carried out, and that the protective surgeon's formula increased.

Noting that obesity is effective in uterine cancers, Gültekin pointed out that in these studies health said that it was emphasized that a significant part of the uterine cancer could be prevented by obesity prevention.

Vaccination with 9 in cervical cancer

On the other hand, in the symposium, 9 new vaccines in cervical cancer treatment world Health Organization It was handled by HPV specialists.

World Health Organization HPV Center Coordinator Dr. Xavier Bosch , regarding the vaccine, noted:

"The cervical cancer is caused by the HPV virus, and two different vaccines against HPV have been used, two and four, which are effective against two and four HPV types, and the new generation vaccine is effective against 9 HPV types.

The vaccine, European union licensed for use in all women over the age of 9 in the countries entered the use. In this way, a new strategy for cervical cancer control has developed.

Preliminary results showed that the new generation vaccine is 90 percent more successful than other vaccines in preventing cancer development caused by HPV-associated infections. "